Introduction and objective
Dyspnoea is a major symptom in COPD patients, but the determinants that could be associated with a higher dyspnoea mMRC score in COPD patients remain unclear. Our research aimed to study the determinants of dyspnoea at the threshold of 1, 2, 3 and 4 mMRC.
Patients and methods
Diagnosis of COPD was made using spirometry with post-bronchodilator . An online questionnaire has been employed by pulmonologists to recruit COPD patients. The following variables were collected: age, gender, BMI, FEV1, RV, IC, TLC, FRC, mMRC, frequency of exacerbations and comorbidities. The LASSO was used to select the variables associated with the mMRC dyspnoea scale in a subgroup (who had no missing IC, RV and FRC values) of 421 COPD patients defined by the previously mentioned variables.
One thousand nine hundred and sevety-three patients (65.3% males, average age=66±10, 38% current smokers) were included. Dyspnoea was correlated with a low FEV1 and with the number of exacerbations in the past 12 months. Multivariate analysis showed that the determinants of dyspnoea(mMRC≥2) are: FEV1: OR=3.71[2.86–4.82]; anxiety: OR=2.52[1.82–3.47]; cough: OR=1.94[1.57–2.40]; bronchiectasis: OR=1.84[1.03–3.29]; age: OR=1.80[1.45–2.24]; hyperinflation (RV/TLC): OR=1.68[1.34–2.11]; ischemic cardiopathy: OR=1.63[1.22–2.18]; hypertension: OR=1.52[1.21–1.91]; exacerbations (≥2): OR=1.41[1.10–1.81]; women: OR=1.39[1.10–1.74] and overweight: OR=1.33[1.06–1.67]. The subgroup analysis showed that: FEV1: OR=3.47[1.96–6.12]; exacerbations (≥2) OR=2.31[1.33–4.17] and hyperinflation (IC/TLC) OR=0.57[0.35–0.85] were associated with higher dyspnoea (mMRC≥2).
Our results showed that dyspnoea is related to the severity of airflow limitation, gender, exacerbations, comorbidities and hyperinflation.El texto completo de este artículo está disponible en PDF.
Keywords : COPD, Dyspnoea, mMRC, Hyperinflation, Sensitivity analysis
Abbreviations : COPD, mMRC, FEV1, FVC, BMI, RV, IC, TLC, FRC, LASSO
Vol 79Artículo 100803- mai 2021 Regresar al número
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.